Edward Fang

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

Philippe Prokocimer, Carisa De Anda, Edward Fang et al. · JAMA · 2013 · 352 citations

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

Gregory J. Moran, Edward Fang, G. Ralph Corey et al. · The Lancet Infectious Diseases · 2014 · 301 citations

Antimicrobial Susceptibility, Antibiotics, Skin-structure Infections +8

Inflammatory Mediators Induced by Amyloid-Beta in the Retina and RPE In Vivo: Implications for Inflammasome Activation in Age-Related Macular Degeneration

Ruozhou Tom Liu, Jiangyuan Gao, Sijia Cao et al. · Investigative Ophthalmology & Visual Science · 2013 · 148 citations · Full text

Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections

Andrew F. Shorr, Thomas P. Lodise, G. Ralph Corey et al. · Antimicrobial Agents and Chemotherapy · 2014 · 140 citations · Full text

Antibiotic Adjuvant, Pharmacotherapy, Antimicrobial Chemotherapy +17

<i>In Vitro</i> , <i>In Vivo</i> , and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions

Shawn D. Flanagan, Ken Bartizal, Sonia L. Minassian et al. · Antimicrobial Agents and Chemotherapy · 2013 · 100 citations · Full text

Psychotropic Medication, Pharmacotherapy, Experimental Pharmacology +22